Pharmaceutical Executive January 16, 2024
Investors may be attracted to precision medicine and gene therapy in the coming year due to a variety of reasons, including the treatments’ abilities to produce exact responses.
Gene therapy and precision medicine continue to grow within the life sciences industry. When looking at trends for the coming year, it’s easy to say that researchers will continue to pursue more personalized forms of treatment.
Mark Melton, vice president of scientific operations and development at Slope, has a more specific view on trends for the coming year. He recently spoke with Pharmaceutical Executive about precision medicine and what he expects from it in 2024. According to him, the major trend for the coming year will be focused on investments.
“I think...
Today's Sponsors
Today's Sponsor